miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 12, 2026

Aduro Clean Technologies erreicht wichtigen Meilenstein: Übergang seiner NGP-Pilotanlage in Phase der Betriebskampagne

View original at globenewswire.com
Aduro Clean Technologies erreicht wichtigen Meilenstein: Übergang seiner NGP-Pilotanlage in Phase der Betriebskampagne LONDON, Ontario, Feb…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This milestone is the result of disciplined execution by our engineering, operations, and project teams. With the NGP pilot plant now in structured test operation, it becomes an important asset paving our path to commercialization and deepening collaboration with partners

    80% confidence
  • The FOAK plant site has been selected and ongoing activities in London will flow directly into design and integration planning, strengthening the company's readiness to execute the next phase of scale-up

    80% confidence
  • Aduro is well positioned to generate relevant operational and environmental performance data that will support and advance its commercialization program

    80% confidence
  • These campaigns serve to refine operating parameters for optimal yield and consistent performance with varying feedstocks while simultaneously validating design assumptions for the industrial FOAK plant

    80% confidence
  • The NGP pilot plant is operating as expected and initial campaigns align with planned test series

    80% confidence
  • After commissioning, our main focus is on operating the integrated system and the insights gained from it. The NGP pilot plant expands on investigations conducted in the R2 flow reactor and enables us to test mixed plastic waste samples from customer programs and other real-world sources under longer run times and more integrated operating conditions

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Aduro Clean Technologies erreicht wichtigen Meilenstein: Übergang seiner NGP-Pilotanlage in Phase der Betriebskampagne — Source | Via News | es.VIA.NEWS